Ocumetra is proud to announce the launch of mEYE Suite, groundbreaking all-in-one myopia management software designed to eliminate barriers to effective treatment and enhance patient outcomes.
Built on a global database of over one million records and an extensive body of scientific literature, mEYE Suite empowers eyecare professionals (ECPs) with the tools they need to confidently manage myopia with evidence-based, personalized care.
mEYE Suite integrates three powerful core modules: mEYE Guide, mEYE Gauge, and brand new mEYE Score. Together, they provide a comprehensive parental/ guardian communication and clinical decision-support system, reducing chair time, building confidence and optimizing treatment outcomes.
"For many eyecare professionals, promoting myopia management as a standard of care can be challenging," said James Loughman, CEO. "mEYE Suite removes the burden of 'selling' myopia management, allowing ECPs to focus on clinical necessity rather than price. It alleviates this challenge by shifting the conversation from costs to risks and benefits, fostering greater acceptance and confidence among parents."
With intuitive centile charts, interactive vision simulations, axial length estimations, analytics, and treatment benefit indices, mEYE Suite enhances clinical confidence and patient engagement by:
- Maximizing treatment uptake through clear, personalized communication tools.
- Demonstrating treatment efficacy to parents, improving compliance and long-term retention even when myopia progression occurs.
- Reducing axial length anxiety among practitioners without a biometer yet, providing an estimated axial length.
- Optimizing chair time with streamlined decision-making and predictive analytics.
- Supporting compliance with professional guidelines and the new standard of care requirements for myopia management.
- Enhancing and standardizing the patient and parent journey in myopia management, improving experience, trust, and the practice’s reputation.
mEYE Suite is a web-based platform that requires no additional software installation and is accessible from any modern browser. Additional key features include:
- Single Sign-On Access; ensure a secure and hassle-free user experience.
- Multilingual Capabilities; allows clinicians to communicate with parents in their local language—new languages added monthly!
- Data Security Compliance; GDPR and HIPAA compliant ensuring patient information is handled safely without storing personally identifiable data.
- Parent-Friendly Design; simplifying complex myopia information for easier understanding and decision-making.
With mEYE Suite, eyecare professionals can now provide a higher level of care, ensuring better vision health for the next generation.
mEYE Suite is now available for eyecare professionals worldwide. For more information or to request a demo, visit www.ocumetra.com or contact info@ocumetra.com.
Alternatively, catch Ocumetra and mEYE Suite at Launchpad Innovation Zone at booth P1473 at Vision Expo East 2025.
About Ocumetra
Ocumetra is a global leader in myopia management, offering innovative tools and solutions to support all stakeholders in the myopia management sector. Our transformative platform empowers eye care professionals, optical groups, myopia treatment manufacturers, and diagnostic device companies to deliver clinical excellence, optimize operational efficiency, and expand market opportunities.
Our partnership approach is designed to help build successful and impactful myopia management programs, ensuring both clinical excellence and commercial success.
Our product portfolio includes:
- Clinical Decision Support Tools: Effective, streamlined patient communication, integrate refraction and axial length monitoring, and support evidence-based treatment decisions and personalized care.
- Marketing and Professional Services: Enable practices and optical groups to attract, retain, and engage patients effectively while delivering superior care.
- Data Analytics and Business Intelligence: Provide actionable insights to optimize clinical and operational outcomes.
By driving proactive myopia management adoption, Ocumetra accelerates market growth, ensures compliance with evolving standards of care, and improves outcomes for children worldwide. Learn more at Ocumetra.com.